Biogen, Inc. (BIIB)
196.45
-0.52
(-0.26%)
USD |
NASDAQ |
May 28, 16:00
196.45
0.00 (0.00%)
After-Hours: 18:27
Biogen Research and Development Expense (Annual) : 1.481B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| Gilead Sciences, Inc. | 5.688B |
| AbbVie, Inc. | 8.249B |
| Apellis Pharmaceuticals, Inc. (DELISTED) | 295.85M |
| Moderna, Inc. | 2.917B |